Related Experiment Video
Updated: Feb 12, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
Diabetes and Parkinson disease: A sweet spot?
1From the Department of Neurology and Neurotherapeutics (R.R.D.), University of Texas Southwestern Medical Center, Dallas; Health Services Research and Development Service (R.R.D.), Roudebush Veterans Affairs Medical Center, Indianapolis, IN; and Department of Neurology (M.M.U.), Saarland University, Homburg/Saar, Germany. rohit.das@utsouthwestern.edu.
No abstract available in PubMed .
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer
Diabetes: Symptoms, Diagnosis, and Complications

